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Abstract
Background: The purpose of this study was to investigate the effects of sub-chronic high fat, high sucrose diet
(also termed ‘Westernized diet’ or WD) feeding on the liver transcriptome during early nonalcoholic fatty liver disease
(NAFLD) development.
Methods: Brown Norway male rats (9 months of age) were randomly assigned to receive ad libitum access to
a control (CTL; 14 % kcal fat, 1.2 % sucrose by weight) diet or WD (42 % kcal from fat, 34 % sucrose by
weight) for 6 weeks.
Results: Six weeks of WD feeding caused hepatic steatosis development as evidenced by the 2.25-fold increase in
liver triacylglycerol content, but did not induce advanced liver disease (i.e., no overt inflammation or fibrosis) in adult
Brown Norway rats. RNA deep sequencing (RNA-seq) revealed that 94 transcripts were altered in liver by WD feeding
(46 up-, 48 down-regulated, FDR < 0.05). Specifically, the top differentially regulated gene network by WD feeding was
‘Lipid metabolism, small molecular biochemistry, vitamin and mineral metabolism’ (Ingenuity Pathway Analysis (IPA)
score 61). The top-regulated canonical signaling pathway in WD-fed rats was the ‘Superpathway of cholesterol
biosynthesis’ (10/29 genes regulated, p = 1.68E-17), which coincides with a tendency for serum cholesterol levels
to increase in WD-fed rats (p = 0.09). Remarkably, liver stearoyl-CoA desaturase (Scd) mRNA expression was by far
the most highly-induced transcript in WD-fed rats (approximately 30-fold, FDR = 0.01) which supports previous
literature underscoring this gene as a crucial target during NAFLD development.
Conclusions: In summary, sub-chronic WD feeding appears to increase hepatic steatosis development over a
6-week period but only induces select inflammation-related liver transcripts, mostly acute phase response genes.
These findings continue to outline the early stages of NAFLD development prior to overt liver inflammation and
advanced liver disease.
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Background
Many modernized cultures consume a high-fat, high
sugar diet rich in calories, termed a Western diet (WD),
which contributes to obesity-related maladies. Concomi-
tant with the staggering rise in the obesity epidemic is
the prevalence of nonalcoholic fatty liver disease
(NAFLD) which is now estimated to affect ~30 % of the
adult population in the United States, and is present in
75–100 % of obese or morbidly obese individuals [1, 2].
NAFLD is a progressive liver disease ranging from sim-
ple steatosis, nonalcoholic steatohepatitis (NASH), fibro-
sis, and cirrhosis [3]. It is characterized by elevated
hepatic triglyceride (TG) storage (≥5 % by weight) in the
absence of excessive alcohol consumption (<20 g/d) and
is considered to be the hepatic manifestation of the
metabolic syndrome (reviewed in [3]).
Western Diet (WD) feeding in rodents leads to the
rapid development of NAFLD and subsequent develop-
ment of NASH [4]. High-fat and/or high-sugar feeding
studies examining the liver transcriptome have reported
that inflammatory and lipid metabolism markers in-
crease while oxidative stress defense markers decrease
following 4–20 weeks of high fat diet feeding [5–8]. A
more recent publication examining numerous transcrip-
tomic studies identified 31 hepatic gene candidates that
are induced in mice following a high fat diet [9]; specif-
ically, mRNAs related to fatty acid β-oxidation, fatty acid
synthesis, and gluconeogenesis were up-regulated;
whereas, genes involved in sterol biosynthesis, insulin
signaling, and oxidative stress defense were down-
regulated following high fat feeding. Therefore, it is ap-
parent that high-fat/high-sugar diets exert profound and
rapid alterations in the liver transcriptome which pre-
cede and/or coincide with disease progression.
We recently performed a sub-chronic (6-week) feeding
study examining the effects of an antioxidant supple-
ment on markers of liver health during concomitant
WD feeding in 9-month old adult Brown-Norway rats
[10]. When comparing WD ad libitum-fed rats versus
rats provided control diet (CTL; low fat, low sugar)
groups, we found pronounced hepatic lipid accumula-
tion, as determined by Oil Red O and H&E staining,
suggestive of a NAFLD phenotype. However, it remains
to be determined if lipid accumulation with sub-chronic
WD feeding altered or coincided with serum and liver
markers suggestive of a pro-inflammatory response. Fur-
thermore, there are a limited number of investigations
having examined global transcriptomic changes in the
liver during the early stages of WD feeding. The infor-
mation will lead to better understanding of early pro-
gression of fatty liver disease, and will help to identify
potential interventional targets. Therefore, the purpose
of the current study was to examine how 6 weeks of
WD versus CTL feedings in adult Brown Norway rats: a)
affects the liver transcriptome, and b) affects select
serum and liver pro-inflammatory and fibrotic markers.
Methods
Animals and dietary feeding paradigm
All experimental protocols were approved by the
University of Missouri’s Animal Care and Use Com-
mittee. Nine-month-old male Brown Norway rats
(Charles River Laboratory, O’ Fallon, Missouri) were
assigned to one of the following two groups for
6 weeks: 1) ad libitum WD feeding (WD; n = 8); and
2) ad libitum low-fat/low sugar diet (CTL; n = 6).
WD (TD.88137; Harlan Laboratories) contained the
following nutrient make-up: 4.5 kcal/g, 15.2 % protein
(expressed as %kcal), 42.7 % carbohydrate (expressed
as %kcal), 42.0 % fat (expressed as %kcal), and 0.2 %
cholesterol (by weight). Of note, this diet has been
used in prior rodent studies to elicit NASH [11, 12].
CTL (LabDiet® Certified CR 14 % protein rodent diet)
contained the following nutrient make-up: 3.5 kcal/g,
16.1 % protein (expressed as %kcal), 69.3 %
carbohydrate (expressed as %kcal), 14.6 % fat
(expressed as %kcal), and 0.014 % cholesterol (by
weight). WD also contained a high proportion of su-
crose (34 % of the total diet by weight), whereas CTL
did not (1.2 % of the total diet by weight).
Rats were singly housed in standard rat cages in
temperature-controlled animal quarters (21 °C) with a
0700–1900 light: 1900–0700 dark cycle that was main-
tained throughout the experimental period. Food intakes
were carefully measured weekly (i.e., monitoring cage
bottoms for morsels, etc.) and total caloric intakes for
the duration of the study have been reported elsewhere
[10].
Euthanasia procedures
Euthanasia procedures have been described in detail
elsewhere [10]. Briefly, on the day of euthanasia, animal
cages were removed from the animal quarters between
0800–0900 and food was removed from each cage.
Euthanasia took place between 1400–1900 and rats were
sacrificed under CO2 gas in their home cages in order to
minimize stress. Whole blood was subsequently removed
via heart sticks using a 21-gauge needle and syringe,
placed in a serum separator tube, centrifuged at 3200
rev/min for 5 min, serum was aliquoted into 1.7 ml
microcentrifuge tubes, and serum was flash frozen for
later serum cytokine assessment. Separate median lobe
liver sections (~50–100 mg) were subsequently removed
using standard dissection techniques and were flash fro-
zen in liquid nitrogen for RNA deep-sequencing proce-
dures, NF-κB pathway phosphoprotein analysis, and
liver trichrome staining and triacylglycerol (TAG) ana-
lysis respectively.
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Liver trichrome staining and TAG content
Histochemical intrahepatic TAG content was deter-
mined as previously described [13]. To examine liver
morphology, formalin-fixed, paraffin-embedded livers
were sectioned and stained with trichrome stain for col-
lagen deposition/fibrosis.
Liver RNA-seq methods
RNA isolation and cDNA preparation Two micro-
grams of liver RNA from WD (n = 6) and CTL (n = 6)
rats were sent to the University of Missouri’s DNA Core
for RNA-seq procedures. Of note, only 6 of the 8 WD
rats were used for RNA-seq due to resource constraints.
High RNA integrity of each sample was confirmed using
the BioAnalyzer 2100 automated electrophoresis system
(Bio-Rad, Hercules, CA, USA) prior to cDNA library
construction. cDNA library preparation was subse-
quently performed using the manufacturer’s protocol
with reagents supplied in Illumina’s TruSeq RNA sample
preparation kit v2. Poly-A containing mRNA was puri-
fied from 2 μg of total RNA, RNA was fragmented,
double-stranded cDNA was generated from fragmented
RNA and the index containing sample identifier adapters
were ligated to the ends. The final construct of each
purified library was evaluated using the BioAnalyzer
2100 automated electrophoresis system, quantified with
the Qubit fluorometer using the quant-iT HS dsDNA re-
agent kit (Invitrogen, Life Technologies, Grand Island,
NY), and diluted according to Illumina’s standard se-
quencing protocol for sequencing on the HiSeq 2000.
Illumina sequencing of NAc cDNA and statistical
analyses of RNA-seq data RNA-seq procedures
occurred at the University of Missouri DNA Core and
are described in more detail elsewhere [14]. Briefly, fol-
lowing cDNA library construction, samples were loaded
onto a flow cell where clusters of each oligo were repli-
cated. Following this procedure, flow cells were placed
in the sequencer and fluorescently-labeled bases were at-
tached to the complementary bases of each sequence.
The Illumina Genome Analyzer recorded 50 bp reads.
Reads were trimmed to ensure adaptor sequence re-
moval and tiled to a custom reference using NextGENe
v1.92 (SoftGenetics, State College, PA).
Liver NF-κB pathway phosphoprotein determination
Briefly, 50–100 mg of excised liver tissue was homoge-
nized on ice in RIPA buffer [50 mM Tris–HCl (pH 8.0),
150 mM NaCl, 1 % NP-40, 0.5 % sodium deoxycholate,
1 % SDS, 1x protease inhibitor, phosphatase II and III in-
hibitor cocktails (Sigma, St. Louis, MO, USA)] using a
Tissuelyser (Qiagen, Valencia, CA, USA) at 20 Hz for
1 min. The homogenate was centrifuged at 12,000 g for
10 min and the resultant supernatant was obtained for
Western blotting. Protein concentrations were obtained
using the BCA assay (Pierce Biotechnology, Rockford,
IL) and 60 μg of protein in loading buffer was loaded
onto 18 % SDS-PAGE gels. Proteins were transferred
onto PVDF membranes and primary antibodies [rabbit
monoclonal phospho-IkBα (Ser32) at 1:1,000, pan mouse
monoclonal IkBα at 1:1,000, pan rabbit monoclonal
phospho-NF-κB (Ser536) at 1:1,000, and pan rabbit
monoclonal phospho-NF-κB at 1:1,000 (Cell Signaling,
Danvers, MA, USA)], diluted in Tris-buffered saline +
Tween20 with 5 % bovine serum albumin were applied
to membranes overnight at 4 °C. HRP-conjugated sec-
ondary antibody (1:2,000; Cell Signaling), were applied
for 1 h at room temperature, and ECL substrate (Pierce
Biotechnology) was then applied for 5 min prior to ex-
posure. Band densitometry was performed through the
use of Kodak 4000R Imager and Molecular Imagery
Software (Kodak Molecular Imaging Systems, New
Haven, CT).
Serum cytokine profile determination
Serum samples were assayed in duplicate for concentra-
tions of leptin, IL-1β, IL-6, MCP-1, and TNF-α using a
multiplex cytokine assay (Millipore Milliplex, cat no.
RCYTOMAG-80 K; Billerica, MA, USA) on a MAGPIX
instrument (Luminex Technologies; Luminex, Austin,
TX, USA) according to the manufacturer’s instructions.
Statistics and bioinformatics for liver RNA-seq data
Differential gene expression patterns were analyzed for
annotated genes between the WD and CTL groups using
reads per kilobase per million mapped reads (RPKM)
values. Differentially expressed liver mRNAs were con-
sidered to be significant when WD/CTL fold-change
false discovery rate (FDR) p-values were < 0.05. Liver
transcripts that were found to be altered with WD feed-
ing were subsequently entered into Ingenuity Pathway
Analysis (Qiagen) to elucidate gene networks and/or
biological functions within the liver that were altered.
Statistics for non-RNA-seq data
Unless otherwise stated, dependent variables are pre-
sented as mean ± standard error and between-group
comparisons were performed using independent samples
t-tests. Significance was set at an alpha level of 0.05.
Results
Phenotypic changes following 6 weeks of WD versus CTL
feeding
Phenotypic changes in WD versus CTL rats are pre-
sented in Table 1 below. As reported previously [10],
WD feeding significantly increased body mass at sacri-
fice by 6 % (p = 0.0019), omental fat pad mass by 52 %
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(p < 0.001), perirenal fat pad mass by 74 % (p < 0.001),
and liver fat deposition by 4.2-fold (p = 0.004). We also
previously reported that WD rats consumed 15 % more
calories compared to CTL rats (p < 0.001), with a diet
higher in total fat, total sucrose, and total cholesterol.
We also expand upon our previous findings of increases
in neutral lipid staining by Oil-Red O in WD rats by
reporting that liver TAG content was 2.2 fold higher in
WD versus CTL rats (p < 0.001; Table 1). Moreover, tri-
chrome staining revealed no difference in liver fibrosis
in WD versus CTL rats (data not shown).
WD feeding disrupts the hepatic expression of genes
involved with cholesterol and fatty acid synthesis
Using a statistical cut-off of FDR < 0.05, we demonstrate
that 6 weeks of WD feeding up-regulated 46 liver tran-
scripts and down-regulated 48 transcripts. IPA readouts
demonstrate that the top regulated gene network in WD
versus CTL rats included ‘Lipid metabolism, small mo-
lecular biochemistry, vitamin and mineral metabolism’
(IPA score 61; Fig. 1). Serum cholesterol levels tended to
be higher in WD-fed rats as previously reported [10]
(Fig. 2a), which coincides with the aforementioned
RNA-seq readout suggesting a dysregulation in choles-
terol biosynthesis-related transcripts in WD versus CTL
rats (Fig. 2b). Interestingly, the top regulated canonical
signaling pathway in WD versus CTL rats was the
‘Superpathway of cholesterol biosynthesis’ (10/29 genes
down-regulated, p = 1.68E-17; Fig. 2c).
Of the transcripts meeting the statistical cut-off of
FDR < 0.05, only 4 mRNAs were up-regulated > 2.0-fold
between WD versus CTL rats, whereas 17 mRNAs were
down-regulated > −2.0-fold (Table 2); most of these be-
ing involved with cholesterol biosynthesis (WD/CTL
mRNA fold change: Cyp51a1 −8.43, Tm7sf2 −8.39,
Hmgcs1 −6.82, Msmo1 −6.48, Insig1 −4.71, Fdps −3.74,
Pcsk9 −3.56, Lss −2.39, Pmvk −2.28), fatty acid synthesis
(WD/CTL mRNA fold change: Scd +28.4, Fads1 −3.74,
Acly −2.88, Acss2 −2.43) and drug metabolism (WD/
CTL mRNA fold change: Cyp2c18 + 2.50, Cyp51a1
−8.43, Ugt2a3 −2.13).
WD feeding does not affect systemic or hepatic pro-
inflammatory markers, but modestly affects markers of
the acute phase protein response
Surprisingly, six weeks of WD feeding did not signifi-
cantly affect serum cytokines (Fig. 3a-e) and/or liver
phospho-IkBα and/or phospho-NF-κB p65 patterns
(Fig. 3f/g). Likewise, RNA-seq readouts for genes related
to TNF-α signaling, IL-6 signaling, and IL-1β signaling
suggest that 6 weeks of WD feeding only elicits modest
alterations in pro-inflammatory cytokine pathway signal-
ing genes (Table 3). Specifically, IL-1β mRNA and Jak3
mRNA (IL-6 downstream effector) were up-regulated in
WD versus CTL rats (nominal p-value < 0.05), albeit
these increases did not meet the FDR cut-off values.
Interestingly, WD feeding caused a differential regula-
tion of liver mRNAs related to the acute phase response
(Table 3). Specifically, WD feeding caused an up-
regulation in platelet factor 4 (Pf4) mRNA (Table 3)
which is a putative chemoattractant protein that recruits
neutrophils and monocytes. When examining a
Table 1 Animal characteristics following 6 weeks of WD versus CTL feeding
Variable CTL WD p-value
Body and tissue masses
Body mass at sacrifice (g) 329 ± 7 350 ± 12 0.002
Omental fat mass (g) 0.25 ± 0.03 0.38 ± 0.03 <0.001
Perirenal fat mass (g) 1.70 ± 0.14 2.95 ± 0.40 <0.001
Dietary data
Total kcal consumed 2,488 ± 32 2,849 ± 38 <0.001
Total protein consumed (g) 100 ± 1 110 ± 1 <0.001
Total carbohydrate consumed (g) 461 ± 6 307 ± 4 <0.001
Total fat consumed (g) 40 ± 1 134 ± 2 <0.001
Total sucrose consumed (g) 8.5 ± 0.1 215 ± 3 <0.001
Total cholesterol consumed (g) 0.099 ± 0.001 1.27 ± 0.02 <0.001
Liver characteristics
Fat deposition (Oil-Red O area; AUs) 167.6 ± 51.3 701.3 ± 139.5 0.004
Liver TAGs (nmol/g tissue) 3.34 ± 0.25 7.53 ± 0.58 <0.001
Values are means ± SE. Body mass, total kcal consumed, and Oil-Red O data previously reported [10]; symbols: g, grams; AUs, arbitrary units
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spectrum of acute phase response genes, WD feeding
also significantly increased serum amyloid P component
(Apcs) mRNA, haptoglobin (Hb) mRNA and super-
oxide dismutase 2 (Sod2) mRNA while significantly
decreasing apolipoprotein H (Apoh) mRNA and lipo-
polysaccharide binding protein (Lpb) mRNA. Finally,
WD feeding down-regulated the mRNA expression of
the growth hormone receptor (Ghr) (WD/CTL: −1.33,
FDR = 0.04). This is of particular interest given that:
a) the liver is a very responsive tissue to growth hor-
mone, and b) the macrophage-specific knockout of
Ghr causes an enhanced inflammatory response in
peripheral tissues when animals were challenged with
a high-fat diet [15]. Collectively, these modest tran-
script alterations may be initial changes that occur
with the development of WD-induced liver
Fig. 1 The top regulated gene network in WD versus CTL rats. The top regulated gene network in WD versus CTL rats included ‘Lipid metabolism,
small molecular biochemistry, vitamin and mineral metabolism’ (IPA score 61; Fig. 1). Specific hubs down-regulated (green) in WD were Srebp2, Insig1,
and Cyp51a1. Scd is the only molecule in the shown network to be up-regulated. Molecules shown in the network are: Acly, ATP citrate lyase; Acss2,
acyl-CoA synthetase short-chain family member 2; Adhfe1, alcohol dehydrogenase, iron containing, 1; Apoh, apolipoprotein H (beta-2-glycoprotein I);
Cyp51a1, cytochrome P450, family 51, subfamily A, polypeptide 1; Ebp, emopamil binding protein (sterol isomerase); Fads1, fatty acid desaturase 1; Fdft1,
farnesyl-diphosphate farnesyltransferase 1; Ghr, growth hormone receptor; Hmgcs1, 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble); Hp,
haptoglobin; Hsd11b1, hydroxysteroid (11-beta) dehydrogenase 1; Insig1, insulin induced gene 1; Irf6, interferon regulatory factor 6; Lipc,
hepatic lipase, hepatic; Lss, lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase); Msmo1, methylsterol monooxygenase 1; Nucb2,
nucleobindin 2; Pcsk9, proprotein convertase subtilisin/kexin type 9; Pmvk, phosphomevalonate kinase; Pon3, paraoxonase 3; Sc5d, sterol-C5-desaturase;
Scd, stearoyl-CoA desaturase (delta-9-desaturase); Srebf2, sterol regulatory element binding transcription factor 2; Stard4, StAR-related lipid transfer
(START) domain containing 4; Tm7sf2, transmembrane 7 superfamily member 2
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inflammation that has been shown to occur with lon-
ger feeding schedules [16, 17].
Discussion
These RNA-seq data-mining efforts provide a unique
snapshot of liver transcriptomic alterations that occur
with sub-chronic WD feeding in adult Brown Norway
rats. While it has demonstrated that longer high-fat/
high-sugar feeding schedules cause increases in liver in-
flammation [17], oxidative stress [18], fibrosis [17, 18]
and mitochondrial dysfunction [19, 20], we here provide
evidence that sub-chronic WD feeding causes a rapid
dysregulation in select hepatic lipid and cholesterol me-
tabolism genes in rats; an effect which: a) may contrib-
ute to the doubling in hepatic TG content presented
herein; and b) may be responsible for serum cholesterol
levels tending to increase after 6 weeks of WD feeding
as previously reported [10]. Furthermore, the RNA-seq
analyses reveal that while a large majority of pro-
inflammatory mediators remained unaltered with west-
ern diet feeding, select liver transcripts related to acute-
phase inflammation signaling were altered with sub-
chronic WD feeding in the setting of hepatic steatosis.
Six weeks of WD feeding primarily affect hepatic mRNA
expression patterns related to lipid metabolism and
cholesterol biosynthesis
The primary finding from the current study is that sub-
chronic WD feeding causes rapid alterations in select lipid
and cholesterol metabolism genes which, in turn, likely
contributes to the observed increases in liver fat accumu-
lation and dysregulation of serum cholesterol levels.
The striking 28.3-fold increase in liver Scd1 mRNA
with 6 weeks of WD feeding emphasizes the potential
importance of this gene in the development of
NAFLD. The Scd1 enzyme catalyzes monounsaturated
long-chain fatty acid synthesis from saturated fatty
acyl-CoAs [21], and Scd1-deficient mice have been
Fig. 2 WD feeding dysregulates hepatic cholesterol biosynthesis gene expression. Values are means ± SE for Panel a. Total serum cholesterol
(a) tended to be higher in WD. and transcript levels of a number of cholesterol biosynthesis genes unaltered with WD feeding (b, all responses
p < 0.05). Top Regulator Effector Network in IPA (c) involved in the regulation of cholesterol biosynthesis. Cyp51a1, cytochrome P450, family 51,
subfamily A, polypeptide 1; Ebp, emopamil binding protein (sterol isomerase); Fdft1, farnesyl-diphosphate farnesyltransferase 1; Fdps, farnesyl diphosphate
synthase; Hmgcs1, 3-hydroxy-3-methylglutaryl-CoA synthase 1; Lss, lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase); Msmo1,
methylsterol monooxygenase 1; Pmvk, phosphomevalonate kinase; Sc5d, sterol-C5-desaturase; Tm7sf2, transmembrane 7 superfamily member 2; Adrb,
Beta Adrenergic Receptor; Atp7b, ATPase, Cu++ transporting, beta polypeptide; Insig1, insulin induced gene 1; Pex5l, peroxisomal biogenesis factor 5-like;
Srebf2, sterol regulatory element binding factor 2
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Table 2 Up- and down-regulated annotated liver transcripts on a fold-change basis with WD feeding







Top transcripts up-regulated with WD feeding (FDR < 0.05, > 2.0 fold-change)
Stearoyl-CoA desaturase
(delta-9-desaturase) (Scd)
Involved in fatty acid biosynthesis, primarily the synthesis
of oleic acid; linked to inhibition of CPT-1A and suppression
of mitochondrial fatty acid oxidation
28.392 0.01 0.00004
PDZ and LIM domain 1
(Pdlim1)
Cytoskeletal protein that may act as an adapter that brings
other proteins (like kinases) to the cytoskeleton
2.741 0.006 0.00002
Cytochrome P450, family 2,
subfamily C, polypeptide 18
(Cyp2c18)
This gene encodes a member of the cytochrome P450 superfamily
of enzymes which are monooxygenases that catalyze reactions
involved in drug metabolism and synthesis of cholesterol, steroids and other lipids
2.504 0.01 0.00003
Platelet factor 4 (Pf4) Chemotactic molecule for neutrophil and monocyte attraction 2.031 0.04 0.0004
Top transcripts down-regulated with WD feeding (FDR < 0.05, < −2.0 fold-change)
Cytochrome P450, family 51,
subfamily A, polypeptide 1
(Cyp51a1)
This gene encodes a member of the cytochrome P450 superfamily
of enzymes which are monooxygenases that catalyze reactions





Involved in the conversion of lanosterol to cholesterol −8.381 0.007 0.00002
3-hydroxy-3-methylglutaryl-
CoA synthase 1 (Hmgcs1)
This enzyme condenses acetyl-CoA with acetoacetyl-CoA to form




The protein is localized to the endoplasmic reticulum membrane
and is believed to function in cholesterol biosynthesis
−6.482 0.002 0.000002
Zinc finger protein 48 (Znf48) May be involved in transcriptional regulation −6.458 0.00006 0.00000001
Insulin induced gene 1 (Insig1) Mediates feedback control of cholesterol synthesis −4.711 0.03 0.0002
RUN and SH3 domain
containing 1 (Rusc1)
Seems to be involved in signaling pathways that are regulated by





Involved in cholesterol synthesis −4.275 0.0003 0.0000003
Fatty acid desaturase 1 (Fads1) Component of a lipid metabolic pathway that catalyzes biosynthesis of
unsaturated fatty acids polyunsaturated fatty acids
−3.735 0.004 0.000007
Proprotein convertase
subtilisin/kexin type 9 (Pcsk9)
Acts via a non-proteolytic mechanism to enhance the degradation of the




Plays a role in multiple biological processes as the rate-limiting enzyme
in taurine biosynthesis
−3.023 0.049 0.0005
ATP citrate lyase (Acly) ATP citrate-lyase is the primary enzyme responsible for the synthesis of
cytosolic acetyl-CoA in many tissues; has a central role in de novo lipid synthesis
−2.879 0.049 0.0006
Acyl-CoA synthetase short-
chain family member 2 (Acss2)






Catalyzes the cyclization of (S)-2,3 oxidosqualene to lanosterol, a reaction that




Gene is ubiquitously expressed but liver function unknown −2.344 0.02 0.0002
Phosphomevalonate kinase
(Pmvk)




UDP-glucuronosyltransferases are involved in the elimination of potentially toxic
xenobiotics and endogenous compounds
−2.129 0.009 0.00003
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shown to possess less liver fat accumulation [22–24].
Indeed, pharmacologically [25] and genetically [26]
knocking down Scd1 has been shown to favorably
alter fatty acid composition in mouse liver tissue.
Thus, our data is in agreement with the aforemen-
tioned literature suggesting that a dietary-induced
overexpression of liver Scd1 may be crucial in the
early development of NAFLD. Liver cytochrome P450
polypeptide 18 (Cyp2c18) was also up-regulated 2.7-
fold in WD versus CTL rats. In adipocytes, Cyp2c18
is thought to work in concert with Scd1 to oxidize
fatty acids once they are desaturated [27]. Cyp2c18 is
also thought to be involved in hepatic arachidonic
acid and linoleic acid metabolism [28] and has been
shown to be up-regulated in other models of NAFLD
[29].
Contrary to a select number of hepatic genes being >2-
fold up-regulated in WD versus CTL rats, more hepatic
genes were >2-fold down-regulated in WD versus CTL
rats with several of these genes being involved in choles-
terol biosynthesis which is likely a partial reflection in the




Fig. 3 Effects of WD feeding on systemic and hepatic pro-inflammatory markers. Serum concentrations of leptin (a), IL-1β (b), IL-6 (c), MCP-1 (d),
and TNF-α (e). Hepatic protein content for phospho-IkBα and phospho-p65 (f & g). Values are means ± SE. WD feeding tended to elevate serum
leptin compared to CTL rats (p = 0.07), while not affecting other pro-inflammatory serum markers. Moreover, WD feeding did not affect liver markers of
NF-κB signaling
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Table 3 Select liver transcripts in WD versus CTL rats related to pro-inflammatory cytokine, acute-phase protein response, and
macrophage infiltration
Transcript CTL RPKM mean WD RPKM mean WD/CTL Fold-change Nominal p-value
Select genes involved in IL-6 signaling
IL-6 not on RNA-seq readout
IL-6R 29.55 30.89 1.05 0.80
gp130 26.04 23.44 −1.11 0.44
Jak1 34.9 34.1 −1.02 0.66
Jak2 1.87 1.81 −1.03 0.78
Jak3 2.02 2.78 1.37 0.034
Stat3 15.43 16.20 1.05 0.68
Socs3 2.49 3.44 1.38 0.47
Select genes involved in TNF-α signaling
TNF-α 0.02 0.03 1.56 0.38
Tnfrsf1b 3.91 2.88 −1.36 0.08
Traf2 6.96 7.06 1.01 0.81
Rela (p65) 10.56 10.64 1.01 0.89
Nfkbia (IkBa) 18.57 18.35 −1.01 0.90
Select genes involved in IL-1β signaling
IL-1β 1.99 2.93 1.47 0.013
IL-1R1 6.38 6.79 1.07 0.75
Traf6 1.45 1.30 −1.12 0.23
Mapk8 (JNK1) 2.24 1.98 −1.13 0.32
Mapk9 (JNK2) 18.27 19.25 1.05 0.52
Select genes encoding acute phase response proteins
Apcs 1048 862 −1.22 0.047
Apoh 3874 3401 −1.07 0.006
C2 51.0 47.0 −1.09 0.10
C9 517 614 1.19 0.10
Crp not on RNA-seq readout
F2 1051 1060 1.01 0.86
Fth1 1817 1969 1.08 0.18
Hmox1 16.3 17.0 1.05 0.62
Hp 1299 1603 1.24 0.0002
Hpx 2667 3086 1.16 0.11
IL-1rn 13.7 11.5 −1.19 0.35
Lbp 538 350 −1.54 0.002
Mur2 432 392 −1.10 0.31
Pf4 2.48 5.04 2.03 0.0004
Plg 944 868 −1.08 0.11
Sod2 41.8 47.2 1.13 0.013
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hepatic Tm7sf2, which encodes the endoplasmic reticulum
enzyme 3β-hydroxysterol Δ14-reductase that is involved
with cholesterol biosynthesis [30], was robustly down-
regulated with WD feeding. Recent evidence suggests that
Tm7sf2−/− mice present increases in NF-κB activation; this
being a hallmark feature of inflammation signaling. Thus,
while markers of NF-κB signaling were not altered with
WD feeding in the current study, this may be an early tran-
scriptomic event that precedes NF-κB signaling with
NAFLD development. Other notable hepatic genes down-
regulated in WD included: a) Cyp51a1 and Fdps which have
been genotype-associated with higher HDL-C levels [31]
and NAFLD [32] in humans, respectively; b) Hmgcs1 which
has been shown to be positively associated with HDL-C
levels [33]; and c) Insig1 which is a gene that, when overex-
pressed in livers of Zucker diabetic fatty rats, attenuates hep-
atic steatosis [34]. Interestingly, hepatic Pcsk9, which
encodes for a serine protease that reduces LDL receptor con-
tent [35], was paradoxically down-regulated in WD versus
CTL rats. The WD-induced down-regulation in hepatic Acly
mRNA is also paradoxical given that its inhibition in db/db
mice has been shown to markedly protect against de novo
lipogenesis and hepatic steatosis [36]. Notwithstanding, we
contend that the marked dysregulation in hepatic lipid me-
tabolism and cholesterol biosynthesis genes after 6 weeks of
WD feeding is reflective of the phenotypic changes we re-
port at the tissue level. Moreover, these genetic alterations
likely precede hepatic inflammation and fibrosis development.
Six weeks of WD feeding affect select hepatic acute phase
protein and fibrosis-related mRNA expression patterns,
but not local or systemic pro-inflammatory biomarkers
Various markers of liver inflammation were generally
not elevated with 6 weeks of WD feeding in adult Brown
Norway rats despite significant development of hepatic
steatosis. These results extend mouse data to rats. Stan-
ton et al. [16] previously demonstrated that C57BL/6
mice fed a high fat/high cholesterol diet for 6 weeks did
not present increases in several pro-inflammatory liver
chemokine mRNAs, but instead presented significant in-
creases in these markers 16 and 26 weeks after feeding.
Notwithstanding, we demonstrated that the mRNA ex-
pression of numerous acute phase proteins was altered
(some increasing while others decreasing) following
6 weeks of WD feeding in adult rats. Acute phase pro-
teins are proteins produced by the liver that are thought
to increase or decrease in the plasma by 25 % in re-
sponse to an immunological or inflammatory stimulus
[37]. The presence of an acute phase response to
NAFLD and NASH also extends to mouse data [38, 39].
Radonjic et al. [40] demonstrated that liver mRNAs for
several acute phase reactants within days of high-fat diet
feeding in ApoE3L mice. Hence, our current data suggests
that liver acute phase response genes can be induced early
during WD-induced NAFLD; a finding which may demar-
cate an early pro-inflammatory stimulus.
Interestingly, the 2-fold WD-induced increase in hep-
atic platelet factor 4 (Pf4 or Cxcl4) mRNA may be an
early indicator or even initiator of fibrosis that follows
the development of NAFLD. To our knowledge, no
other studies using models of NAFLD have shown this
gene to change, although Pf4 has been shown to induce
fibrosis [41]. Indeed, Pf4 mRNA has been shown to be
up-regulated in alcoholic hepatitis patients [42]. Recom-
binant murine Cxcl4 has also been shown to stimulate
the proliferation, chemotaxis, and chemokine expression
of hepatic stellate cells [41]; a phenomena which sug-
gests that there may be a potential role for its induction
in the development of nonalcoholic steatohepatitis.
Of the serum pro-inflammatory cytokines measured in
the current study, only serum leptin tended to be 2.4
times greater in WD versus CTL rats. Indeed longer
high-fat and/or high-sugar feeding schedules have been
shown to increase serum levels of select pro-
inflammatory cytokines [43]. While leptin is mainly
regarded as an adipokine involved with appetite regula-
tion, some evidence supports its role in promoting an
inflammation response [44, 45]. For instance, leptin-
deficient ob/ob mice present with impairments in
macrophage function [46]. Other studies have also
shown that leptin is required for hepatic fibrosis devel-
opment in leptin-deficient ob/ob mice model [47, 48].
Table 3 Select liver transcripts in WD versus CTL rats related to pro-inflammatory cytokine, acute-phase protein response, and
macrophage infiltration (Continued)
Select genes representative of macrophage markers
Cd68 12.69 12.94 1.02 0.86
Emr1 (F4/80) 4.33 4.89 1.13 0.32
Itgax (Cd11c) 0.27 0.42 1.53 0.044
Itgam (Cd11b) 0.37 0.37 −1.01 0.92
Bold-faced transcript indicates that nominal p-values < 0.05
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Thus, our data supports the hypothesis that WD-
induced increases in leptin levels may precede and even
be permissive for subsequent liver fibrosis to occur with
a longer term WD challenge.
Finally, the lack of increased NF-κB signaling in WD-fed
rats may be due to the short-term feeding schedule
employed in the current study. Indeed, genetically-altered
murine models (Ldlr−/−, and Apoe2-knock-in) have been
shown to present robust hepatic inflammation (via NF-κB
signaling) and steatosis within 21 days of high fat/high
cholesterol feeding, although wild-type mice in this same
study developed only ectopic fat deposition without overt
inflammation [49]. Notwithstanding, the 6-week WD
feeding in the current study caused hepatic steatosis but
appeared to be insufficient in duration to develop histo-
logical NASH with inflammation and fibrosis.
Conclusions
The current study provides a unique perspective in
adult rats as to how a Westernized diet affects liver
transcriptomic changes over an initial 6-week feeding
period. The transcriptome-wide interrogation
employed herein gives insight into the rapid liver
gene expression changes that occur with early WD-
induced hepatic steatosis development prior to the
development of secondary outcomes (i.e., inflamma-
tion and fibrosis) and support other transcriptomic
work in this sub-chronic timeframe [50, 51]. This
study points to the potential sensitivity of the rodent
liver to dietary fat, sucrose, and cholesterol and helps
add to the framework for other researchers interested
in examining gene targets or metabolic pathways that
occur with NASH development. Our data suggest that
the expression of numerous lipid metabolism and
cholesterol biosynthesis genes are rapidly altered with
sub-chronic WD feeding; an effect which was mani-
fested with significant hepatic steatosis. Furthermore,
the 28-fold increase in liver Scd1 mRNA with sub-
chronic WD feeding continues to underscore the po-
tential importance of this gene in the development of
NAFLD. While WD feeding caused alterations in se-
lect acute phase response mRNAs, other pro-
inflammatory signaling mediators and mRNAs appear
unaltered with 6 weeks of WD feeding. Hence, this
may suggest that diet-induced liver fibrosis and in-
flammation may either: a) occur much later with
more chronic WD rat feeding paradigms; and/or b)
may be initiated by other factors that precede even-
tual perturbations in local and systemic pro-
inflammatory signalers with chronic WD feeding.
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